Study S001133

Comparison of the Effects of Monotherapy With Exenatide or Metformin to Combined Exenatide and Metformin Therapy on Menstrual Cyclicity in Overweight Women With Polycystic Ovary Syndrome

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00344851
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 60
Start: 2006-06
Lead sponsor: Metabolic Center of Louisiana Research Foundation
Conditions: Polycystic Ovary Syndrome
Interventions: DRUG:metformin, exenatide or combined (metformin & exenatide )
Results posted: FALSE

Registered primary outcomes

- Menstrual Cyclicity ( # menses/ 24 weeks) [every 4 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0028017	Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. Elkind-Hirsch K, The Journal of clinical endocrinology and metabolism	2008	Randomized trial	PMID 18460557 DOI	cites ClinicalTrials.gov:NCT00344851; registry reference DERIVED:18460557